E-mail

E-mail a Wiley Online Library Link

Ruben J. Boado, Jeff Zhiqiang Lu, Eric K.-W. Hui, Rachita K. Sumbria and William M. Pardridge Pharmacokinetics and brain uptake in the rhesus monkey of a fusion protein of arylsulfatase a and a monoclonal antibody against the human insulin receptor Biotechnology and Bioengineering 110

Version of Record online: 25 DEC 2012 | DOI: 10.1002/bit.24795

Thumbnail image of graphical abstract

Targeted-delivery of the lysosomal enzyme, arylsulfatase A (ASA), across the blood-brain barrier (BBB) for treatment of the brain in metachromatic leukodystrophy is possible following the re-engineering of the enzyme as an IgG-enzyme fusion protein. The IgG domain of the fusion protein is a genetically engineered monoclonal antibody (MAb) against the human insulin receptor (HIR). The monoclonal antibody acts as a molecular Trojan horse to ferry the enzyme into brain via transport on the endogenous BBB insulin receptor.

Complete the form below and we will send an e-mail message containing a link to the selected article on your behalf

Required = Required Field

SEARCH